[HTML][HTML] Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

J Root, P Merino, A Nuckols, M Johnson… - Neurobiology of disease, 2021 - Elsevier
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal
neurodegenerative disorders that are thought to exist on a clinical and pathological …

Neuronal ceroid lipofuscinosis: the multifaceted approach to the clinical issues, an overview

A Simonati, RE Williams - Frontiers in neurology, 2022 - frontiersin.org
The main aim of this review is to summarize the current state-of-art in the field of childhood
Neuronal Ceroid Lipofuscinosis (NCL), a group of rare neurodegenerative disorders. These …

The genetic basis of phenotypic heterogeneity in the neuronal ceroid lipofuscinoses

E Gardner, SE Mole - Frontiers in Neurology, 2021 - frontiersin.org
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative
disorders that affect children and adults. They share some similar clinical features and the …

[HTML][HTML] Gene therapy for lysosomal storage disorders: ongoing studies and clinical development

G Massaro, AF Geard, W Liu, O Coombe-Tennant… - Biomolecules, 2021 - mdpi.com
Rare monogenic disorders such as lysosomal diseases have been at the forefront in the
development of novel treatments where therapeutic options are either limited or unavailable …

Drug delivery pathways to the central nervous system via the brain glymphatic system circumventing the blood‐brain barrier

X Wang, Y Yin, H Zhou, B Chi, L Guan, P Li, J Li… - …, 2024 - Wiley Online Library
The blood‐brain barrier (BBB) poses daunting challenges in treating diseases associated
with the central nervous system (CNS). Recently, the traditional notion of the absence of the …

Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2

D Sondhi, SM Kaminsky, NR Hackett… - Science translational …, 2020 - science.org
Late infantile Batten disease (CLN2 disease) is an autosomal recessive, neurodegenerative
lysosomal storage disease caused by mutations in the CLN2 gene encoding tripeptidyl …

Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders

M Placci, MI Giannotti, S Muro - Advanced drug delivery reviews, 2023 - Elsevier
Lysosomes play a central role in cellular homeostasis and alterations in this compartment
associate with many diseases. The most studied example is that of lysosomal storage …

[HTML][HTML] Pathomechanisms in the neuronal ceroid lipofuscinoses

HR Nelvagal, J Lange, K Takahashi… - … et Biophysica Acta (BBA …, 2020 - Elsevier
The neuronal ceroid lipofuscinoses (NCLs) are a group of inherited neurodegenerative
lysosomal storage disorders (LSDs), traditionally grouped together based on shared clinical …

Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms

V Huin, M Barbier, A Bottani, JA Lobrinus, F Clot… - Brain, 2020 - academic.oup.com
Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid
lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar …

Gene therapy ameliorates bowel dysmotility and enteric neuron degeneration and extends survival in lysosomal storage disorder mouse models

EA Ziółkowska, MJ Jansen, LL Williams… - Science translational …, 2025 - science.org
Children with neurodegenerative disease often have debilitating gastrointestinal symptoms.
We hypothesized that this may be due at least in part to underappreciated degeneration of …